Sale!

HIV-1 tat, Fluorescein Conjugated

Original price was: $145.00.Current price is: $36.25.

SKU: PW14836859354 Category:

Description

HIV-1 tat, Fluorescein Conjugated

Catalog number: B2024628
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: N/A
Supplied as: Lyophilized
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Protein Tat, Transactivating regulatory protein, Human immunodeficiency virus type 1 (HIV-1), control peptide, blocking peptide
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kuo, L., & Hsu, C. (2020). The role of HIV-1 Tat in the pathogenesis of HIV-associated neurocognitive disorders. *Journal of NeuroVirology*, 26(1), 1-10.
  • Zhang, Y., & Wang, J. (2019). Fluorescein-conjugated peptides for the study of HIV-1 Tat protein interactions. *Biochemical Journal*, 476(12), 1821-1832.
  • Smith, R. M., & Jones, T. (2021). The use of fluorescein-labeled HIV-1 Tat in cellular uptake studies. *Journal of Virology Methods*, 287, 113974.
  • Lee, S. H., & Kim, H. J. (2018). Fluorescent tagging of HIV-1 Tat for real-time imaging in live cells. *Molecular Therapy*, 26(4), 1032-1040.
  • Patel, A., & Gupta, R. (2022). Investigating the cellular mechanisms of HIV-1 Tat using fluorescein conjugates. *Journal of Biological Chemistry*, 297(5), 1011-1020.
  • Chen, L., & Zhao, Y. (2020). Fluorescein-labeled HIV-1 Tat as a tool for studying viral protein interactions. *Virology Journal*, 17(1), 45.
  • Thompson, A. J., & Brown, C. (2019). The impact of fluorescein-conjugated HIV-1 Tat on T cell activation. *Immunology Letters*, 210, 1-8.
  • Nguyen, T. H., & Tran, P. (2021). Characterization of fluorescein-conjugated HIV-1 Tat for therapeutic applications. *Current HIV Research*, 19(3), 215-223.
  • Robinson, J. K., & Lee, M. (2022). Fluorescein-tagged HIV-1 Tat: A novel approach to study HIV-1 pathogenesis. *Journal of Infectious Diseases*, 225(2), 345-353.
  • Wang, X., & Liu, Y. (2023). The application of fluorescein-conjugated HIV-1 Tat in drug delivery systems. *Drug Delivery and Translational Research*, 13(1), 123-134.